Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FAAY0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,780
Award facts
- Contract value 100% obligated
- $44,780.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,780.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (semaglutide injection), a GLP-1 receptor agonist used for weight management. The contract, issued on October 30, 2025, with completion targeted for October 31, 2025, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This delivery order was competitively awarded without set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open competition. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
This award is a child contract under AmerisourceBergen's $999.999 billion IDC with DLA Troop Support Medical, which runs through December 2026 and serves as the primary vehicle for supplying pharmaceuticals and medical commodities to military healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen supplies the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The DLA's Pharmaceutical Prime Vendor Global Program is planning Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the key vendors supporting military medical supply chains.
Quick answers
Who was awarded contract SPE2DB26FAAY0?
SPE2DB26FAAY0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FAAY0 worth?
The government has obligated $44,780 on SPE2DB26FAAY0.
Is contract SPE2DB26FAAY0 an order under another contract?
Yes. SPE2DB26FAAY0 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FAAY0 competed?
The extent of competition for SPE2DB26FAAY0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award